The Trump administration unveiled a new policy restricting annual COVID-19 vaccinations, primarily targeting adults 65 and older and those with health conditions. The FDA announced this shift, emphasizing the need for extensive studies before approving vaccines for healthier individuals. This decision raises concerns about access for those who may still want the vaccine, as the availability could be limited for healthy younger adults and children. The change reflects broader scrutiny over vaccine distribution and usage, marking a significant shift in pandemic response strategies.
"Is the pharmacist going to determine if you're in a high-risk group? The only thing that can come of this will make vaccines less insurable and less available."
"The upcoming changes raise questions for people who may still want a fall COVID-19 shot but don't clearly fit into one of the categories."
Collection
[
|
...
]